Experimentally, the most sensitive NB cells to MDM2 inhibition have been shown to have MYCN amplification, suggesting that MYCN may play a prominent role in the MDM2/p53 axis.21, 25, 26. This evidence concerns the gene TP53 and neuroblastoma.